 |  |  |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| _____________________________________________________________________________________________________________________ © 2005-11 All Rights Reserved. NOD Pharmaceuticals, Inc. |
NOD Pharmaceuticals, Inc., an innovative biotech company focusing on oral delivery of
biopharmaceuticals, aims to become the leader in this field. NOD has developed a patented platform
technology, NOD tech, to enable oral delivery of biopharmaceuticals by using bio-adhesive
nano-particle as carrier and unidirectional release enhanced absorption dosage form.
Our leading product candidate, Nodlin, an oral insulin formulation developed with NOD tech, is
currently in Phase 1 trial. Please refer to the product page for details.
biopharmaceuticals, aims to become the leader in this field. NOD has developed a patented platform
technology, NOD tech, to enable oral delivery of biopharmaceuticals by using bio-adhesive
nano-particle as carrier and unidirectional release enhanced absorption dosage form.
Our leading product candidate, Nodlin, an oral insulin formulation developed with NOD tech, is
currently in Phase 1 trial. Please refer to the product page for details.
Emerging Leader in Oral Delivery of Biopharmaceuticals
-Innovation Delivered
| News |